Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis

NCT00570622 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT00570622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00570622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis
Lead sponsor
Medical University of Vienna
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2004
Completion date
November 30, 2008
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ascites, cirrhosis, portal hypertension